
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-8258669d.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-f4a99799.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            A comparative analysis of Palbociclib and Ribociclib in metastatic hormone receptor-positive, HER2-negative breast cancer: a prospective mid term follow-Up study from an Indian cohort - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="D2E4BBA28AF4347305BBA2001B10012C.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="bmccanc">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12362974/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="BMC Cancer">
<meta name="citation_title" content="A comparative analysis of Palbociclib and Ribociclib in metastatic hormone receptor-positive, HER2-negative breast cancer: a prospective mid term follow-Up study from an Indian cohort">
<meta name="citation_author" content="Nihanthy D Sreenath">
<meta name="citation_author_institution" content="Saroj Gupta Cancer Centre &amp; Research Institute, Kolkata, India">
<meta name="citation_author" content="Suresh Pandalanghat">
<meta name="citation_author_institution" content="Medicine &amp; Medical Oncology, Army Hospital (R&amp;R), New Delhi, India">
<meta name="citation_author" content="Amul Kapoor">
<meta name="citation_author_institution" content="Medicine &amp; Medical Oncology, Army Hospital (R&amp;R), New Delhi, India">
<meta name="citation_author" content="Rajath Govind">
<meta name="citation_author_institution" content="Medicine &amp; Medical Oncology, Army Hospital (R&amp;R), New Delhi, India">
<meta name="citation_author" content="M R Kaushik">
<meta name="citation_author_institution" content="Medicine &amp; Medical Oncology, INHS Asvini, Mumbai, India">
<meta name="citation_author" content="Rajesh Nair">
<meta name="citation_author_institution" content="Medicine &amp; Medical Oncology, Command Hospital (Central Command), Lucknow, India">
<meta name="citation_author" content="Dipen Bhuva">
<meta name="citation_author_institution" content="Blood and Cancer Institute, Surat, India">
<meta name="citation_author" content="Anvesh Rathore">
<meta name="citation_author_institution" content="Medicine &amp; Medical Oncology, Army Hospital (R&amp;R), New Delhi, India">
<meta name="citation_author" content="Manish Kumar">
<meta name="citation_author_institution" content="Medicine &amp; Medical Oncology, Army Hospital (R&amp;R), New Delhi, India">
<meta name="citation_author" content="Deepak Mulajker">
<meta name="citation_author_institution" content="Medicine &amp; Medical Oncology, Army Hospital (R&amp;R), New Delhi, India">
<meta name="citation_publication_date" content="2025 Aug 18">
<meta name="citation_volume" content="25">
<meta name="citation_firstpage" content="1337">
<meta name="citation_doi" content="10.1186/s12885-025-14270-1">
<meta name="citation_pmid" content="40826034">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12362974/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12362974/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12362974/pdf/12885_2025_Article_14270.pdf">
<meta name="description" content="Cyclin-dependent kinase 4/6 (CDK4/6) inhibitors, such as Palbociclib and Ribociclib, have significantly improved outcomes for patients with hormone receptor-positive, HER2-negative (HR+/HER2-) advanced breast cancer. Although clinical trials have ...">
<meta name="og:title" content="A comparative analysis of Palbociclib and Ribociclib in metastatic hormone receptor-positive, HER2-negative breast cancer: a prospective mid term follow-Up study from an Indian cohort">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="Cyclin-dependent kinase 4/6 (CDK4/6) inhibitors, such as Palbociclib and Ribociclib, have significantly improved outcomes for patients with hormone receptor-positive, HER2-negative (HR+/HER2-) advanced breast cancer. Although clinical trials have ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12362974/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-header data-testid="header"    >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            <a class="ncbi-header__logo-container"
               href="https://www.ncbi.nlm.nih.gov/">
                <img alt="NCBI home page"
                     class="ncbi-header__logo-image"
                     src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg"
                     width="410"
                     height="100" />
            </a>

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="desktop-navigation-search-form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only" for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  action="https://www.ncbi.nlm.nih.gov/search/all/"
                  
                  autocomplete="off"
                  data-testid="mobile-navigation-search-form"
                  method="GET"
                  role="search">
                <label class="usa-sr-only" for="search-field-mobile-navigation">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="term" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://www.ncbi.nlm.nih.gov/pmc/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
                
                    <button form="pmc-search-form" formaction="https://pmc.ncbi.nlm.nih.gov/search/" type="submit" class="usa-button usa-button--unstyled hover:text-no-underline text-no-underline width-auto margin-top-1 tablet:margin-top-0">
     <span class="bg-green-label padding-05 text-white">New</span><span class="text-underline text-primary">Try this search in PMC Beta Search</span>
</button>
                
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="12362974">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.1186/s12885-025-14270-1"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/12885_2025_Article_14270.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12362974%2F%3Freport%3Dclassic%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/12362974/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/12362974/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12362974/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-bmccanc.png" alt="BMC Cancer logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to BMC Cancer" title="Link to BMC Cancer" shape="default" href="https://doi.org/10.1186/s12885-025-14270-1" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">BMC Cancer</button></div>. 2025 Aug 18;25:1337. doi: <a href="https://doi.org/10.1186/s12885-025-14270-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1186/s12885-025-14270-1</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/pmc/?term=%22BMC%20Cancer%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22BMC%20Cancer%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22BMC%20Cancer%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22BMC%20Cancer%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>A comparative analysis of Palbociclib and Ribociclib in metastatic hormone receptor-positive, HER2-negative breast cancer: a prospective mid term follow-Up study from an Indian cohort</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Sreenath%20ND%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Nihanthy D Sreenath</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Nihanthy D Sreenath</span></h3>
<div class="p">
<sup>1</sup>Saroj Gupta Cancer Centre &amp; Research Institute, Kolkata, India </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Sreenath%20ND%22%5BAuthor%5D" class="usa-link"><span class="name western">Nihanthy D Sreenath</span></a>
</div>
</div>
<sup>1,</sup><sup>✉</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Pandalanghat%20S%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Suresh Pandalanghat</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Suresh Pandalanghat</span></h3>
<div class="p">
<sup>2</sup>Medicine &amp; Medical Oncology, Army Hospital (R&amp;R), New Delhi, India </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Pandalanghat%20S%22%5BAuthor%5D" class="usa-link"><span class="name western">Suresh Pandalanghat</span></a>
</div>
</div>
<sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Kapoor%20A%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Amul Kapoor</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Amul Kapoor</span></h3>
<div class="p">
<sup>2</sup>Medicine &amp; Medical Oncology, Army Hospital (R&amp;R), New Delhi, India </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Kapoor%20A%22%5BAuthor%5D" class="usa-link"><span class="name western">Amul Kapoor</span></a>
</div>
</div>
<sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Govind%20R%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Rajath Govind</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Rajath Govind</span></h3>
<div class="p">
<sup>2</sup>Medicine &amp; Medical Oncology, Army Hospital (R&amp;R), New Delhi, India </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Govind%20R%22%5BAuthor%5D" class="usa-link"><span class="name western">Rajath Govind</span></a>
</div>
</div>
<sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Kaushik%20MR%22%5BAuthor%5D" class="usa-link" aria-describedby="id5"><span class="name western">M R Kaushik</span></a><div hidden="hidden" id="id5">
<h3><span class="name western">M R Kaushik</span></h3>
<div class="p">
<sup>3</sup>Medicine &amp; Medical Oncology, INHS Asvini, Mumbai, India </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Kaushik%20MR%22%5BAuthor%5D" class="usa-link"><span class="name western">M R Kaushik</span></a>
</div>
</div>
<sup>3</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Nair%20R%22%5BAuthor%5D" class="usa-link" aria-describedby="id6"><span class="name western">Rajesh Nair</span></a><div hidden="hidden" id="id6">
<h3><span class="name western">Rajesh Nair</span></h3>
<div class="p">
<sup>4</sup>Medicine &amp; Medical Oncology, Command Hospital (Central Command), Lucknow, India </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Nair%20R%22%5BAuthor%5D" class="usa-link"><span class="name western">Rajesh Nair</span></a>
</div>
</div>
<sup>4</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Bhuva%20D%22%5BAuthor%5D" class="usa-link" aria-describedby="id7"><span class="name western">Dipen Bhuva</span></a><div hidden="hidden" id="id7">
<h3><span class="name western">Dipen Bhuva</span></h3>
<div class="p">
<sup>5</sup>Blood and Cancer Institute, Surat, India </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Bhuva%20D%22%5BAuthor%5D" class="usa-link"><span class="name western">Dipen Bhuva</span></a>
</div>
</div>
<sup>5</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Rathore%20A%22%5BAuthor%5D" class="usa-link" aria-describedby="id8"><span class="name western">Anvesh Rathore</span></a><div hidden="hidden" id="id8">
<h3><span class="name western">Anvesh Rathore</span></h3>
<div class="p">
<sup>2</sup>Medicine &amp; Medical Oncology, Army Hospital (R&amp;R), New Delhi, India </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Rathore%20A%22%5BAuthor%5D" class="usa-link"><span class="name western">Anvesh Rathore</span></a>
</div>
</div>
<sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Kumar%20M%22%5BAuthor%5D" class="usa-link" aria-describedby="id9"><span class="name western">Manish Kumar</span></a><div hidden="hidden" id="id9">
<h3><span class="name western">Manish Kumar</span></h3>
<div class="p">
<sup>2</sup>Medicine &amp; Medical Oncology, Army Hospital (R&amp;R), New Delhi, India </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Kumar%20M%22%5BAuthor%5D" class="usa-link"><span class="name western">Manish Kumar</span></a>
</div>
</div>
<sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Mulajker%20D%22%5BAuthor%5D" class="usa-link" aria-describedby="id10"><span class="name western">Deepak Mulajker</span></a><div hidden="hidden" id="id10">
<h3><span class="name western">Deepak Mulajker</span></h3>
<div class="p">
<sup>2</sup>Medicine &amp; Medical Oncology, Army Hospital (R&amp;R), New Delhi, India </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Mulajker%20D%22%5BAuthor%5D" class="usa-link"><span class="name western">Deepak Mulajker</span></a>
</div>
</div>
<sup>2</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="Aff1">
<sup>1</sup>Saroj Gupta Cancer Centre &amp; Research Institute, Kolkata, India </div>
<div id="Aff2">
<sup>2</sup>Medicine &amp; Medical Oncology, Army Hospital (R&amp;R), New Delhi, India </div>
<div id="Aff3">
<sup>3</sup>Medicine &amp; Medical Oncology, INHS Asvini, Mumbai, India </div>
<div id="Aff4">
<sup>4</sup>Medicine &amp; Medical Oncology, Command Hospital (Central Command), Lucknow, India </div>
<div id="Aff5">
<sup>5</sup>Blood and Cancer Institute, Surat, India </div>
<div class="author-notes p"><div class="fn" id="_fncrsp93pmc__">
<sup>✉</sup><p class="display-inline">Corresponding author.</p>
</div></div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Received 2024 Dec 17; Accepted 2025 May 5; Collection date 2025.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>© The Author(s) 2025</div>
<p><strong>Open Access</strong> This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <a href="https://creativecommons.org/licenses/by-nc-nd/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://creativecommons.org/licenses/by-nc-nd/4.0/</a>.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC12362974  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40826034/" class="usa-link">40826034</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="Abs1"><h2>Abstract</h2>
<section id="sec1"><h3 class="pmc_sec_title">Introduction</h3>
<p id="Par1">Cyclin-dependent kinase 4/6 (CDK4/6) inhibitors, such as Palbociclib and Ribociclib, have significantly improved outcomes for patients with hormone receptor-positive, HER2-negative (HR+/HER2-) advanced breast cancer. Although clinical trials have established the efficacy of these agents globally, real-world data from India is limited. This study compares the clinical effectiveness and safety profiles of Palbociclib and Ribociclib in a cohort of Indian patients.</p></section><section id="sec2"><h3 class="pmc_sec_title">Materials and methods</h3>
<p id="Par2">This prospective study included 60 patients with metastatic HR+/HER2- breast cancer treated at Army hospitals and research centers in India between 2020 and 2023. Progression-free survival (PFS), overall survival (OS), and safety profiles were analyzed to assess the real-world performance of Palbociclib and Ribociclib. Patients were treated with either Palbociclib or Ribociclib in combination with standard endocrine therapy.</p></section><section id="sec3"><h3 class="pmc_sec_title">Results</h3>
<p id="Par3">Among the 60 patients, the median PFS was 39.40 months for the Palbociclib group and 42.93 months for the Ribociclib group (<em>p</em> = 0.26), indicating no statistically significant difference. The median OS was 41.98 months in the Palbociclib group and 45.51 months in the Ribociclib group (<em>p</em> = 0.15), with Ribociclib showing a slight but non-significant survival advantage. The most common adverse event was neutropenia, which occurred in 26% of patients receiving Palbociclib and 23% of patients on Ribociclib. Deranged liver function tests (LFTs) and fatigue were also reported in both groups.</p></section><section id="sec4"><h3 class="pmc_sec_title">Conclusions</h3>
<p id="Par4">Palbociclib and Ribociclib demonstrated comparable efficacy and safety profiles in this Indian cohort. While no statistically significant differences in PFS or OS were observed, the data suggest a marginal survival benefit with Ribociclib. These findings underscore the importance of individualized treatment plans in HR+/HER2- breast cancer, taking into consideration patient-specific factors. Larger studies with longer follow-up are needed to further clarify the nuances between these two agents.</p></section><section id="sec5"><h3 class="pmc_sec_title">Supplementary Information</h3>
<p>The online version contains supplementary material available at 10.1186/s12885-025-14270-1.</p></section><section id="kwd-group1" lang="en" class="kwd-group"><p><strong>Keywords:</strong> CDK4/6 inhibitors, HR+/HER2- breast cancer, Metastatic breast cancer, Palbociclib, Ribociclib, Real-world evidence</p></section></section><section id="Sec1"><h2 class="pmc_sec_title">Introduction</h2>
<p id="Par5">Breast cancer remains the most prevalent malignancy among women worldwide, contributing significantly to global cancer-related morbidity and mortality. According to the GLOBOCAN 2022 report, the incidence of breast cancer in India is approximately 27.6 per 100,000 women, and it continues to be a leading cause of cancer-related deaths among women. Approximately 10–15% of breast cancer patients present with de-novo metastatic disease at initial diagnosis, while a larger proportion develop metastases following initial early-stage diagnosis and treatment. The increasing incidence of metastatic breast cancer, particularly hormone receptor-positive (HR+), HER2-negative (HER2-) subtypes, accounts for approximately 70–80% of all cases, underscores the urgent need for optimizing therapeutic strategies.</p>
<p id="Par6">While endocrine therapy (ET) has been the mainstay of treatment for HR + breast cancer, many patients eventually develop resistance, particularly in the metastatic setting. This has led to the development of targeted therapies, specifically Cyclin-dependent kinase 4/6 (CDK4/6) inhibitors such as Palbociclib, Ribociclib, and Abemaciclib, which have emerged as pivotal agents in overcoming endocrine resistance and improving clinical outcomes [<a href="#CR1" class="usa-link" aria-describedby="CR1">1</a>–<a href="#CR4" class="usa-link" aria-describedby="CR4">4</a>].</p>
<p id="Par7">Their introduction marked a paradigm shift in managing HR+/HER2- breast cancer, particularly when combined with endocrine therapy. Clinical trials, such as the PALOMA [<a href="#CR5" class="usa-link" aria-describedby="CR5">5</a>, <a href="#CR6" class="usa-link" aria-describedby="CR6">6</a>], MONALEESA [<a href="#CR7" class="usa-link" aria-describedby="CR7">7</a>, <a href="#CR8" class="usa-link" aria-describedby="CR8">8</a>], and MONARCH [<a href="#CR9" class="usa-link" aria-describedby="CR9">9</a>] series, have demonstrated significant improvements in both progression-free survival (PFS) and overall survival (OS) with the addition of CDK4/6 inhibitors to standard endocrine therapy [<a href="#CR10" class="usa-link" aria-describedby="CR10">10</a>–<a href="#CR13" class="usa-link" aria-describedby="CR13">13</a>].</p>
<p id="Par8">Despite the well-established efficacy of CDK4/6 inhibitors such as palbociclib and ribociclib, their usage in India remains constrained by high costs and limited access to advanced treatment centers. These therapies, often unaffordable in public health systems, are primarily available in private hospitals, creating a disparity in access [<a href="#CR14" class="usa-link" aria-describedby="CR14">14</a>–<a href="#CR17" class="usa-link" aria-describedby="CR17">17</a>].</p>
<section id="Sec2"><h3 class="pmc_sec_title">Current use and data gaps</h3>
<p id="Par9">CDK4/6 inhibitors are gaining traction in urban oncology centers, but comprehensive Indian data is sparse. The lack of real-world evidence complicates the application of Western trial outcomes to Indian patients.</p></section><section id="Sec3"><h3 class="pmc_sec_title">Patient considerations</h3>
<p id="Par10">Indian metastatic breast cancer patients frequently present with more aggressive disease and comorbid conditions, raising concerns about drug interactions and toxicity profiles, potentially differing from Western populations. These include younger age at presentation, higher proportion of triple-negative and HER2-positive subtypes, delayed diagnosis, and limited access to healthcare services [<a href="#CR16" class="usa-link" aria-describedby="CR16">16</a>].</p>
<p id="Par11">This comparative study aims to establish critical data on the efficacy and toxicity of CDK4/6 inhibitors in Indian patients, guiding clinical decision-making and influencing policies for better drug accessibility, potentially including generics or subsidized programs.</p></section></section><section id="Sec4"><h2 class="pmc_sec_title">Materials and methods</h2>
<section id="Sec5"><h3 class="pmc_sec_title">Study design and population</h3>
<p id="Par12">This prospective, observational cohort study was conducted at a tertiary care centre of Indian Armed Forces, India between 2020 and 2023. A total of 60 patients with metastatic HR+/HER2- breast cancer were recruited between 2020 and 2021, and followed up till December 2023. Inclusion criteria included Patients age greater than 18 years with histopathologically proven HR positive and HER2 negative breast cancer who had clinical and/or radiological evidence of distant metastases, were included in the study. Patients with metastatic TNBC or Her2Neu or prior exposure to CDK4/6 inhibitors were excluded from the study.</p>
<p id="Par13">Patients were allocated to one of two treatment arms based on physician choice. One group received Palbociclib (125 mg/day), while the other received Ribociclib (600 mg/day), both administered for 21 days. In addition, all patients received concurrent endocrine therapy with letrozole (2.5 mg/day).</p>
<p id="Par14"><strong>End points</strong>: Primary: Progression free survival defined as the time interval in months between the date of starting CDK 4/6 inhibitor and date of first documented clinical and/or radiological disease progression. Secondary endpoints included overall survival (OS), toxicity profiles, and the impact of biomarkers, such as Ki-67, on treatment outcomes. OS was defined as the time interval in months between the date of starting CDK 4/6 inhibitor and death due to any cause.</p>
<p id="Par15">Per routine institutional practice, patients underwent laboratory tests, including blood and radiological examination. Patients underwent laboratory tests, including blood tests, and radiological tests as per routine institutional practice. This included complete blood count (CBC) and serum biochemistry prior to starting CDK 4/6 inhibitor, CBC prior to starting each subsequent cycle, ECG prior to starting ribociclib and then as clinically indicated. Radiological assessment was done with PET-CT scan prior to starting CDK 4/6 inhibitor and once every 3–6 cycles thereafter.</p></section><section id="Sec6"><h3 class="pmc_sec_title">Statistical analysis</h3>
<p id="Par16">PFS and OS were estimated using Kaplan-Meier survival curves, and intergroup comparisons were performed using the log-rank test. A p-value &lt; 0.05 was considered statistically significant. Cox proportional hazards models were used for multivariate analysis, adjusting for age, menopausal status, and biomarker expression. All statistical analyses were performed using SPSS version 26.</p>
<section id="FPar1"><h4 class="pmc_sec_title">Ethics</h4>
<p id="Par17">Army Hospital Research and Referral Institutional Ethics Committee approval for the study was obtained. Written informed consent was obtained from all the participants, and precautions were taken to maintain confidentiality. The procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation and with the Helsinki Declaration of 1964, as revised in 2013.</p></section></section></section><section id="Sec7"><h2 class="pmc_sec_title">Results</h2>
<section id="Sec8"><h3 class="pmc_sec_title">Baseline characteristics</h3>
<p id="Par18">The cohort comprised of 60 patients, equally divided between the Palbociclib and Ribociclib groups. Notably, no significant differences in demographic or baseline characteristics were observed between the two groups (Table <a href="#Tab1" class="usa-link">1</a>).</p>
<section class="tw xbox font-sm" id="Tab1"><h4 class="obj_head">Table 1.</h4>
<div class="caption p"><p>Baseline characteristics</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th align="left" colspan="1" rowspan="1">Baseline Characteristics</th>
<th align="left" colspan="1" rowspan="1">Ribociclib (<em>n</em> = 30)</th>
<th align="left" colspan="1" rowspan="1">Palbociclib (<em>n</em> = 30)</th>
</tr></thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">Mean Age: In Years</td>
<td align="left" colspan="1" rowspan="1">52.87</td>
<td align="left" colspan="1" rowspan="1">55.53</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<p>Menopausal Status</p>
<p>Premenopausal</p>
<p>Postmenopausal</p>
</td>
<td align="left" colspan="1" rowspan="1">
<p>09</p>
<p>21</p>
</td>
<td align="left" colspan="1" rowspan="1">
<p>04</p>
<p>26</p>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<strong>Comorbidities</strong>
</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<p>None</p>
<p>HTN</p>
<p>HCV</p>
</td>
<td align="left" colspan="1" rowspan="1">
<p>27</p>
<p>02</p>
<p>01</p>
</td>
<td align="left" colspan="1" rowspan="1">
<p>28</p>
<p>02</p>
<p>00</p>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Mean BMI (kg/m²)</td>
<td align="left" colspan="1" rowspan="1">21.19</td>
<td align="left" colspan="1" rowspan="1">20.58</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Ki 67% (Median %)</td>
<td align="left" colspan="1" rowspan="1">28.2%</td>
<td align="left" colspan="1" rowspan="1">25%</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">BRCA Mutation</td>
<td align="left" colspan="1" rowspan="1">00</td>
<td align="left" colspan="1" rowspan="1">00</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">ER Positive/PR Positive</td>
<td align="left" colspan="1" rowspan="1">22</td>
<td align="left" colspan="1" rowspan="1">26</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">ER Positive/ PR negative</td>
<td align="left" colspan="1" rowspan="1">08</td>
<td align="left" colspan="1" rowspan="1">04</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<p>3–6</p>
<p>7–8</p>
</td>
<td align="left" colspan="1" rowspan="1">
<p>15</p>
<p>15</p>
</td>
<td align="left" colspan="1" rowspan="1">
<p>09</p>
<p>21</p>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">PR Allred Score</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<p>3–6</p>
<p>7–8</p>
</td>
<td align="left" colspan="1" rowspan="1">
<p>13</p>
<p>09</p>
</td>
<td align="left" colspan="1" rowspan="1">
<p>13</p>
<p>13</p>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">ECOG</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<p>1</p>
<p>2</p>
<p>&gt;=3</p>
</td>
<td align="left" colspan="1" rowspan="1">
<p>08</p>
<p>12</p>
<p>10</p>
</td>
<td align="left" colspan="1" rowspan="1">
<p>10</p>
<p>11</p>
<p>09</p>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Sites of Metastases</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<p>Bone Only</p>
<p>Visceral</p>
<p> I. Lung</p>
<p> II. Liver</p>
<p> III. Brain</p>
<p> IV. Non-Regional nodes</p>
<p>Both</p>
</td>
<td align="left" colspan="1" rowspan="1">
<p>04</p>
<p>22</p>
<p>12</p>
<p>11</p>
<p>01</p>
<p>03</p>
</td>
<td align="left" colspan="1" rowspan="1">
<p>07</p>
<p>15</p>
<p>08</p>
<p>06</p>
<p>04</p>
<p>05</p>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Treatment</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<p>First line</p>
<p>Second line*</p>
</td>
<td align="left" colspan="1" rowspan="1">
<p>30</p>
<p>12</p>
</td>
<td align="left" colspan="1" rowspan="1">
<p>30</p>
<p>13</p>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Death</td>
<td align="left" colspan="1" rowspan="1">08</td>
<td align="left" colspan="1" rowspan="1">10</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/Tab1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="_fn_p84">
<p>* Patients who progressed on first-line CDK4/6 inhibitor plus endocrine therapy underwent further molecular profiling through next-generation sequencing (NGS), including assessment of ESR1, PIK3CA, and AKT pathway alterations. Based on the molecular findings, disease burden, and ECOG performance status, they subsequently received either targeted therapy or palliative single-agent chemotherapy</p>
<p>HTN: Hypertension, HCV: Hepatitis C Virus, BMI: Body Mass Index</p>
</div></div></section></section><section id="Sec9"><h3 class="pmc_sec_title">Efficacy outcomes</h3>
<section id="Sec10"><h4 class="pmc_sec_title">Progression-Free survival (PFS)</h4>
<p id="Par20">Patients in the Ribociclib arm experienced a median PFS of 42.93 months, compared to 39.40 months in the Palbociclib arm. Although not statistically significant (<em>p</em> = 0.26), this trend in favouring of Ribociclib is consistent with results from the MONALEESA trials, which similarly demonstrated prolonged PFS in combination with letrozole (see Fig. <a href="#Fig1" class="usa-link">1</a>).</p>
<figure class="fig xbox font-sm" id="Fig1"><h5 class="obj_head">Fig. 1.</h5>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12362974_12885_2025_14270_Fig1_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f4f/12362974/2eb8ff80e4d9/12885_2025_14270_Fig1_HTML.jpg" loading="lazy" id="d33e578" height="463" width="787" alt="Fig. 1"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Kaplan Meier curve for progression free survival</p></figcaption></figure><section id="FPar2"><h5 class="pmc_sec_title">Overall survival (OS)</h5>
<p id="Par23">The overall survival was also slightly higher in the Ribociclib group, with a median OS of 45.51 months versus 41.98 months for Palbociclib. Again, the difference did not reach statistical significance (<em>p</em> = 0.15), but the marginal improvement in OS supports Ribociclib’s potential benefit in prolonging life in this population (see Fig. <a href="#Fig2" class="usa-link">2</a>).</p>
<figure class="fig xbox font-sm" id="Fig2"><h6 class="obj_head">Fig. 2.</h6>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12362974_12885_2025_14270_Fig2_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f4f/12362974/41372dff8908/12885_2025_14270_Fig2_HTML.jpg" loading="lazy" id="d33e608" height="466" width="787" alt="Fig. 2"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Kaplan Meier curve for overall survival</p></figcaption></figure></section></section></section><section id="Sec11"><h3 class="pmc_sec_title">Safety and toxicity</h3>
<p id="Par26">Both Palbociclib and Ribociclib were well-tolerated, with the most common adverse event being neutropenia. Grade 3/4 neutropenia occurred in 16% of patients receiving Palbociclib and 6% on Ribociclib. The toxicity grading was based on the Common Terminology Criteria for Adverse Events (CTCAE) version 5.0. Other toxicities, including deranged LFTs and fatigue, were comparable between the two groups (Table <a href="#Tab2" class="usa-link">2</a>). Dose adjustments were required in 16% of patients in the Palbociclib cohort, compared to 3% in the Ribociclib cohort, in response to adverse events, ensuring optimal management and treatment continuity (see Figs. <a href="#Fig3" class="usa-link">3</a>, <a href="#Fig4" class="usa-link">4</a> and Tables <a href="#Tab3" class="usa-link">3</a>, <a href="#Tab4" class="usa-link">4</a>).</p>
<section class="tw xbox font-sm" id="Tab2"><h4 class="obj_head">Table 2.</h4>
<div class="caption p"><p>PFS comparison</p></div>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12362974_12885_2025_14270_Tab2_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f4f/12362974/aa8f37a73228/12885_2025_14270_Tab2_HTML.jpg" loading="lazy" id="d33e588" height="207" width="779" alt="graphic file with name 12885_2025_14270_Tab2_HTML.jpg"></a></p>
<div class="p text-right font-secondary"><a href="table/Tab2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section><figure class="fig xbox font-sm" id="Fig3"><h4 class="obj_head">Fig. 3.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12362974_12885_2025_14270_Fig3_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f4f/12362974/94bec4553129/12885_2025_14270_Fig3_HTML.jpg" loading="lazy" id="d33e647" height="462" width="787" alt="Fig. 3"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig3/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Kaplan Meier curve for progression free survival</p></figcaption></figure><figure class="fig xbox font-sm" id="Fig4"><h4 class="obj_head">Fig. 4.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12362974_12885_2025_14270_Fig4_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f4f/12362974/9ea96cbab6cd/12885_2025_14270_Fig4_HTML.jpg" loading="lazy" id="d33e657" height="462" width="787" alt="Fig. 4"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig4/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Kaplan Meier curve for overall survival in perimenopausal sub group</p></figcaption></figure><section class="tw xbox font-sm" id="Tab3"><h4 class="obj_head">Table 3.</h4>
<div class="caption p"><p>OS comparison</p></div>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12362974_12885_2025_14270_Tab3_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f4f/12362974/4af56eca90d0/12885_2025_14270_Tab3_HTML.jpg" loading="lazy" id="d33e618" height="191" width="779" alt="graphic file with name 12885_2025_14270_Tab3_HTML.jpg"></a></p>
<div class="p text-right font-secondary"><a href="table/Tab3/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section><section class="tw xbox font-sm" id="Tab4"><h4 class="obj_head">Table 4.</h4>
<div class="caption p"><p>Adverse events (Based on CTCAE v5.0)</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th align="left" colspan="1" rowspan="1">Adverse Event</th>
<th align="left" colspan="1" rowspan="1">Ribociclib (<em>n</em> = 30)</th>
<th align="left" colspan="1" rowspan="1">Palbociclib (<em>n</em> = 30)</th>
</tr></thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">Neutropenia (%)</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<p> Grade 1/2</p>
<p> Grade 3/4</p>
</td>
<td align="left" colspan="1" rowspan="1">
<p>23</p>
<p>06</p>
</td>
<td align="left" colspan="1" rowspan="1">
<p>26</p>
<p>16</p>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Anemia (%)</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<p> Grade 1/2</p>
<p> Grade 3/4</p>
</td>
<td align="left" colspan="1" rowspan="1">
<p>10</p>
<p>00</p>
</td>
<td align="left" colspan="1" rowspan="1">
<p>30</p>
<p>00</p>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Thrombocytopenia (%)</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<p> Grade 1/2</p>
<p> Grade 3/4</p>
</td>
<td align="left" colspan="1" rowspan="1">
<p>10</p>
<p>00</p>
</td>
<td align="left" colspan="1" rowspan="1">
<p>16</p>
<p>00</p>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Deranged LFTs (%)</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<p> Grade 1/2</p>
<p> Grade 3/4</p>
</td>
<td align="left" colspan="1" rowspan="1">
<p>13</p>
<p>00</p>
</td>
<td align="left" colspan="1" rowspan="1">
<p>10</p>
<p>00</p>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Fatigue (%)</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<p> Grade 1/2</p>
<p> Grade 3/4</p>
</td>
<td align="left" colspan="1" rowspan="1">
<p>26</p>
<p>00</p>
</td>
<td align="left" colspan="1" rowspan="1">
<p>16</p>
<p>00</p>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">QTc prolongation (%)</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<p> Grade 1/2</p>
<p> Grade 3/4</p>
</td>
<td align="left" colspan="1" rowspan="1">
<p>03</p>
<p>00</p>
</td>
<td align="left" colspan="1" rowspan="1">
<p>00</p>
<p>00</p>
</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/Tab4/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section></section></section><section id="Sec12"><h2 class="pmc_sec_title">Discussion</h2>
<p id="Par31">The advent of CDK4/6 inhibitors has marked a pivotal advancement in the treatment of HR-positive, HER2-negative metastatic breast cancer, revolutionizing endocrine-based therapy by significantly improving progression-free survival (PFS) and overall survival (OS). Palbociclib and Ribociclib, two leading agents in this class, have shown remarkable efficacy in halting disease progression when combined with endocrine therapy [<a href="#CR18" class="usa-link" aria-describedby="CR18">18</a>]. However, while both drugs demonstrate clinical benefit, this study provides a deeper insight into their comparative real-world performance, safety profiles, and economic considerations, which have significant implications for their broader application, especially in resource-limited settings such as India.</p>
<p id="Par32">Although Palbociclib and Ribociclib share a common mechanism of CDK4/6 inhibition, they possess distinct pharmacological properties that may influence clinical decision-making. These are summarized in the following Table <a href="#Tab5" class="usa-link">5</a>:</p>
<section class="tw xbox font-sm" id="Tab5"><h3 class="obj_head">Table 5.</h3>
<div class="caption p"><p>Comparative Pharmacological profile of Palbociclib and ribociclib</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th align="left" colspan="1" rowspan="1">Feature</th>
<th align="left" colspan="1" rowspan="1">Palbociclib</th>
<th align="left" colspan="1" rowspan="1">Ribociclib</th>
</tr></thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">Target Selectivity</td>
<td align="left" colspan="1" rowspan="1">CDK4 and CDK6</td>
<td align="left" colspan="1" rowspan="1">CDK4 and CDK6 (slightly more selective for CDK4)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Metabolism</td>
<td align="left" colspan="1" rowspan="1">CYP3A4</td>
<td align="left" colspan="1" rowspan="1">CYP3A4, P-glycoprotein substrate</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Half-life</td>
<td align="left" colspan="1" rowspan="1">~ 29 h</td>
<td align="left" colspan="1" rowspan="1">~ 32 h</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Major Adverse Effects</td>
<td align="left" colspan="1" rowspan="1">Higher incidence of Grade 3–4 neutropenia</td>
<td align="left" colspan="1" rowspan="1">More hepatotoxicity; QT prolongation risk</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Monitoring Requirements</td>
<td align="left" colspan="1" rowspan="1">CBC monitoring for neutropenia</td>
<td align="left" colspan="1" rowspan="1">CBC, LFTs, ECG monitoring</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Dose and Schedule</td>
<td align="left" colspan="1" rowspan="1">125 mg daily, 21 days on/7 days off</td>
<td align="left" colspan="1" rowspan="1">600 mg daily, 21 days on/7 days off</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Food Interaction</td>
<td align="left" colspan="1" rowspan="1">Increased bioavailability with food</td>
<td align="left" colspan="1" rowspan="1">Can be taken with or without food</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/Tab5/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section><p id="Par34">These nuanced differences highlight the importance of tailoring CDK 4/6 inhibitor therapy based on individual patient profiles and potential adverse effects [<a href="#CR19" class="usa-link" aria-describedby="CR19">19</a>].</p>
<p id="Par35">In terms of real-world efficacy, the study demonstrates comparable efficacy between Palbociclib and Ribociclib, consistent with findings from the PALOMA and MONALEESA trials. Despite a trend favoring Ribociclib in both PFS (42.93 months vs. 39.40 months for Palbociclib) and OS (45.51 months versus 41.98 months for Palbociclib), these differences did not reach statistical significance. This suggests that both drugs provide substantial benefit when added to endocrine therapy in a real-world cohort, corroborating the results of large randomized trials [<a href="#CR20" class="usa-link" aria-describedby="CR20">20</a>]. The MONALEESA-7 trial, for example, demonstrated an OS benefit of Ribociclib in premenopausal women, while the PALOMA-3 trial established Palbociclib’s efficacy in a more heavily pretreated population.</p>
<p id="Par36">Interestingly, while previous research has pointed to Ribociclib’s superiority in certain subgroups, such as premenopausal women, our findings showed no significant demographic OS or biomarker-driven distinction in outcomes between the two groups. The comparable PFS and OS rates in both cohorts reinforce the idea that either agent may be equally efficacious in the broader population, although more extensive studies with larger sample sizes may better delineate specific populations that benefit more from one agent over the other.</p>
<p id="Par37">Safety remains a primary consideration in CDK4/6 inhibitor therapy, particularly hematological adverse events such as neutropenia. Neutropenia occurred in over 30% of patients in both treatment groups, consistent with global data. However, despite the high incidence of neutropenia, it was largely manageable with dose modifications and supportive care, reflecting the growing familiarity with CDK4/6 inhibitor-related toxicities in clinical practice. Notably, while neutropenia remains a class effect, it rarely leads to life-threatening complications when appropriately managed [<a href="#CR13" class="usa-link" aria-describedby="CR13">13</a>, <a href="#CR21" class="usa-link" aria-describedby="CR21">21</a>–<a href="#CR23" class="usa-link" aria-describedby="CR23">23</a>].</p>
<p id="Par38">A notable finding in this study is the incidence of liver function abnormalities (deranged LFTs) and fatigue, which have been increasingly recognized as significant side effects of both Palbociclib and Ribociclib. In our cohort, 12% of patients on Ribociclib and 10% on Palbociclib experienced elevated LFTs, necessitating dose reductions in some cases. Ribociclib, in particular, has been associated with a higher risk of hepatotoxicity due to its hepatic metabolism. Dose adjustments were required in 16% of patients in the Palbociclib cohort, compared to 3% in the Ribociclib cohort, in response to adverse events, ensuring optimal management and treatment continuity. Dose reductions were implemented in 5 patients on Palbociclib (typically reduced from 125 mg to 100 mg to 75 mg) and in 1 patient on Ribociclib (reduced from 600 mg to 400 mg to 200 mg) due to Grade 3–4 hematologic toxicities.</p>
<p id="Par39">This is consistent with the findings of the MONALEESA trials, which reported liver enzyme elevations more frequently in the Ribociclib arms compared to Palbociclib in the PALOMA trials. In contrast, fatigue, a common but often underestimated adverse effect, occurred in 20% of patients receiving Ribociclib and 18% of those on Palbociclib. Although generally mild, these symptoms can significantly affect quality of life, underscoring the need for proactive symptom management.</p>
<p id="Par40">Economic considerations are increasingly influential in clinical decision-making, especially in low- and middle-income countries. While Palbociclib and Ribociclib have similar price points globally, in India, Palbociclib is generally more affordable, with monthly costs ranging from ₹4000 to ₹80,000 ($60 to $950 USD), compared to ₹75,000 to ₹1,10,000 ($900 to $1,320 USD) for Ribociclib. Given India’s predominantly out-of-pocket healthcare model, these costs can pose substantial financial barriers. Assuming a median treatment duration of 20 months, total drug costs range from ₹80,000 to ₹16,00,000 ($950–$19,000 USD) for Palbociclib, and ₹15,00,000 to ₹22,00,000 ($17,800–$26,200 USD) for Ribociclib [<a href="#CR14" class="usa-link" aria-describedby="CR14">14</a>, <a href="#CR24" class="usa-link" aria-describedby="CR24">24</a>–<a href="#CR27" class="usa-link" aria-describedby="CR27">27</a>].</p>
<p id="Par41">Although formal cost-effectiveness evaluations such as cost per quality-adjusted life year (QALY) are scarce in the Indian context, international data suggest that CDK4/6 inhibitors frequently exceed traditional cost-effectiveness thresholds in resource-limited environments. As such, treatment choices are often influenced by drug availability, patient assistance programs, and institutional procurement practices. There is an urgent need to develop localized pharmacoeconomic models, including assessments of incremental cost-effectiveness ratios (ICERs), to guide rational resource allocation and ensure equitable access to these therapies.</p>
<p id="Par42">In conclusion, the comparable efficacy and safety profiles of Palbociclib and Ribociclib support their interchangeable use in clinical practice, with the choice often dictated by patient-specific factors such as comorbidities, liver function, and economic constraints. The slightly higher risk of hepatotoxicity with Ribociclib may make Palbociclib more favorable in patients with compromised liver function, while Ribociclib’s demonstrated benefit in specific subpopulations in patients with a high-risk or aggressive disease profile.</p>
<p id="Par43">As the field moves toward personalized oncology, future research should focus on identifying robust biomarkers predictive of response to CDK4/6 inhibitors. Although our study found no significant associations with Ki-67 or PIK3CA status, larger, prospective trials are essential to refine treatment strategies and enhance therapeutic precision [<a href="#CR28" class="usa-link" aria-describedby="CR28">28</a>–<a href="#CR30" class="usa-link" aria-describedby="CR30">30</a>].</p>
<section id="FPar3"><h3 class="pmc_sec_title">Limitations</h3>
<p id="Par45">The relatively small sample size, the randomisation, the selection bias, the predominance of postmenopausal patients limits generalizability, particularly regarding younger, premenopausal patients, limited access to subsequent lines of therapy due to suboptimal adherence to treatment, physician discretion or monitoring schedules in real-world settings, differences in patient profiles, loss to follow-up or late-stage presentation impacting OS with limited follow-up duration are limitations of this study, necessitating further research with larger cohorts and longer follow-up to validate these findings.</p></section></section><section id="Sec13"><h2 class="pmc_sec_title">Conclusions</h2>
<p id="Par46">This study provides valuable real-world evidence on the comparative effectiveness and safety of Palbociclib and Ribociclib in an Indian cohort of patients with HR+/HER2- metastatic breast cancer. Both agents demonstrated comparable efficacy, with similar PFS and OS rates. Although Ribociclib exhibited a trend toward improved OS, this difference was not statistically significant. Toxicity profiles were manageable, with neutropenia and liver function abnormalities being the most commonly reported adverse events. Economic considerations remain a considerable challenge in India, where the high cost of these drugs may limit access. Therefore, ongoing research into cost-effective strategies, biomarker-driven treatments, and long-term outcomes is essential to optimize the use of CDK4/6 inhibitors in clinical practice.</p></section><section id="Sec14"><h2 class="pmc_sec_title">Electronic supplementary material</h2>
<p>Below is the link to the electronic supplementary material.</p>
<section class="sm xbox font-sm" id="MOESM1"><div class="media p"><div class="caption">
<a href="/articles/instance/12362974/bin/12885_2025_14270_MOESM1_ESM.docx" data-ga-action="click_feat_suppl" class="usa-link">Supplementary Material 1</a><sup> (75.2KB, docx) </sup>
</div></div></section><section class="sm xbox font-sm" id="MOESM2"><div class="media p"><div class="caption">
<a href="/articles/instance/12362974/bin/12885_2025_14270_MOESM2_ESM.xlsx" data-ga-action="click_feat_suppl" class="usa-link">Supplementary Material 2</a><sup> (16.7KB, xlsx) </sup>
</div></div></section><section class="sm xbox font-sm" id="MOESM3"><div class="media p"><div class="caption">
<a href="/articles/instance/12362974/bin/12885_2025_14270_MOESM3_ESM.docx" data-ga-action="click_feat_suppl" class="usa-link">Supplementary Material 3</a><sup> (46.8KB, docx) </sup>
</div></div></section></section><section id="ack1" class="ack"><h2 class="pmc_sec_title">Acknowledgements</h2>
<p>I would like to extend my deepest gratitude to those whose contributions were invaluable to the completion of this study. First and foremost, I sincerely appreciate of the patients and their families who participated in this study. Without their cooperation and trust, this research would not have been possible. I am especially grateful to my colleagues and mentors, for their insightful guidance, constructive feedback, and unwavering support throughout the study. Their expertise played a critical role in shaping the direction and outcome of this work.</p></section><section id="glossary1" class="glossary"><h2 class="pmc_sec_title">Abbreviations</h2>
<dl class="def-list">
<dt>HR</dt>
<dd><p id="Par52">Hormone Receptor</p></dd>
<dt>HER2</dt>
<dd><p id="Par53">Human Epidermal Growth Factor Receptor 2</p></dd>
<dt>PFS</dt>
<dd><p id="Par54">Progression-Free Survival</p></dd>
<dt>OS</dt>
<dd><p id="Par55">Overall Survival</p></dd>
<dt>CDK 4/6</dt>
<dd><p id="Par56">Cyclin-Dependent Kinase 4/6</p></dd>
<dt>LFT</dt>
<dd><p id="Par57">Liver Function Test</p></dd>
<dt>CI</dt>
<dd><p id="Par58">Confidence Interval</p></dd>
<dt>HR</dt>
<dd><p id="Par59">Hazard Ratio</p></dd>
<dt>SAE</dt>
<dd><p id="Par60">Serious Adverse Event</p></dd>
<dt>AE</dt>
<dd><p id="Par61">Adverse Event</p></dd>
<dt>QoL</dt>
<dd><p id="Par62">Quality of Life</p></dd>
<dt>ECOG</dt>
<dd><p id="Par63">Eastern Cooperative Oncology Group</p></dd>
</dl></section><section id="notes1"><h2 class="pmc_sec_title">Author contributions</h2>
<p>Nihanthy D S: Conceptualization of the study; drafting the original manuscript; writing the first draft; performing revisions; and final approval of the manuscript. Suresh Pandalanghat: Contributions to manuscript writing and editing; revision for critical intellectual content. Amul Kapoor, Rajath Govind, Kaushik M R, Rajesh Nair, Dipen Bhuva, Anvesh Rathore, Manish Kumar, Deepak Mulajker: Supervision of all aspects; reviewing and approving the final version of the manuscript.</p></section><section id="notes2"><h2 class="pmc_sec_title">Funding</h2>
<p>No funding was received for this research.</p></section><section id="notes3"><h2 class="pmc_sec_title">Data availability</h2>
<p>The datasets generated and analyzed during the current study are provided as supplementary material in the form of an MS Excel file for ease of access and reproducibility.</p></section><section id="notes4"><h2 class="pmc_sec_title">Declarations</h2>
<section id="FPar5"><h3 class="pmc_sec_title">Ethical approval</h3>
<p id="Par47">Ethical committee approval was taken. Army Hospital Research and Referral Institutional Ethics Committee (IEC Reg No.-11/2021) approval for the study was obtained. Written informed consent was taken from all the participants with precautions to maintain confidentiality.</p></section><section id="FPar6"><h3 class="pmc_sec_title">Consent to participate</h3>
<p id="Par48">Written informed consent was obtained from the patients.</p></section><section id="FPar7"><h3 class="pmc_sec_title">Consent for publication</h3>
<p id="Par49">Patients have been informed about the publication of their case details in a scientific journal for educational purposes.</p></section><section id="FPar57"><h3 class="pmc_sec_title">Declarations of generative AI and AI-assisted technologies in the writing process</h3>
<p id="Par50">During the preparation of this work the authors used CHAT-GPT in order to improve language and readability. After using this tool/service, the authors reviewed and edited the content as needed and take full responsibility for the publication’s content.</p></section><section id="FPar4"><h3 class="pmc_sec_title">Competing interests</h3>
<p id="Par51">The authors declare no competing interests.</p></section></section><section id="fn-group1" class="fn-group"><h2 class="pmc_sec_title">Footnotes</h2>
<div class="fn-group p font-secondary-light font-sm"><div class="fn p" id="fn1">
<p><strong>Publisher’s note</strong></p>
<p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
</div></div></section><section id="Bib1" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="Bib1_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="CR1">
<span class="label">1.</span><cite>Zhao M, Hanson KA, Zhang Y, Zhou A, Cha-Silva AS. Place in therapy of Cyclin-Dependent kinase 4/6 inhibitors in breast cancer: A targeted literature review. Target Oncol. 2023;18(3):327–58.
</cite> [<a href="https://doi.org/10.1007/s11523-023-00957-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10191980/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37074594/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zhao%20M,%20Hanson%20KA,%20Zhang%20Y,%20Zhou%20A,%20Cha-Silva%20AS.%20Place%20in%20therapy%20of%20Cyclin-Dependent%20kinase%204/6%20inhibitors%20in%20breast%20cancer:%20A%20targeted%20literature%20review.%20Target%20Oncol.%202023;18(3):327%E2%80%9358." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR2">
<span class="label">2.</span><cite>Burstein HJ, Somerfield MR, Barton DL, Dorris A, Fallowfield LJ, Jain D, et al. Endocrine treatment and targeted therapy for hormone receptor–Positive, human epidermal growth factor receptor 2–Negative metastatic breast cancer: ASCO guideline update. J Clin Oncol. 2021;39(35):3959–77.
</cite> [<a href="https://doi.org/10.1200/JCO.21.01392" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8659999/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34324367/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Burstein%20HJ,%20Somerfield%20MR,%20Barton%20DL,%20Dorris%20A,%20Fallowfield%20LJ,%20Jain%20D,%20et%20al.%20Endocrine%20treatment%20and%20targeted%20therapy%20for%20hormone%20receptor%E2%80%93Positive,%20human%20epidermal%20growth%20factor%20receptor%202%E2%80%93Negative%20metastatic%20breast%20cancer:%20ASCO%20guideline%20update.%20J%20Clin%20Oncol.%202021;39(35):3959%E2%80%9377." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR3">
<span class="label">3.</span><cite>Piezzo M, Cocco S, Caputo R, Cianniello D, Gioia GD, Lauro VD, et al. Targeting cell cycle in breast cancer: CDK4/6 inhibitors. Int J Mol Sci. 2020;21(18):6479.
</cite> [<a href="https://doi.org/10.3390/ijms21186479" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7554788/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32899866/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Piezzo%20M,%20Cocco%20S,%20Caputo%20R,%20Cianniello%20D,%20Gioia%20GD,%20Lauro%20VD,%20et%20al.%20Targeting%20cell%20cycle%20in%20breast%20cancer:%20CDK4/6%20inhibitors.%20Int%20J%20Mol%20Sci.%202020;21(18):6479." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR4">
<span class="label">4.</span><cite>Goel S, DeCristo MJ, McAllister SS, Zhao JJ. CDK4/6 Inhibition in cancer: beyond cell cycle arrest. Trends Cell Biol. 2018;28(11):911–25.
</cite> [<a href="https://doi.org/10.1016/j.tcb.2018.07.002" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6689321/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30061045/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Goel%20S,%20DeCristo%20MJ,%20McAllister%20SS,%20Zhao%20JJ.%20CDK4/6%20Inhibition%20in%20cancer:%20beyond%20cell%20cycle%20arrest.%20Trends%20Cell%20Biol.%202018;28(11):911%E2%80%9325." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR5">
<span class="label">5.</span><cite>Turner NC, Ro J, André F, Loi S, Verma S, Iwata H, et al. Palbociclib in Hormone-Receptor-Positive advanced breast Cancer. N Engl J Med. 2015;373(3):209–19.
</cite> [<a href="https://doi.org/10.1056/NEJMoa1505270" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26030518/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Turner%20NC,%20Ro%20J,%20Andr%C3%A9%20F,%20Loi%20S,%20Verma%20S,%20Iwata%20H,%20et%20al.%20Palbociclib%20in%20Hormone-Receptor-Positive%20advanced%20breast%20Cancer.%20N%20Engl%20J%20Med.%202015;373(3):209%E2%80%9319." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR6">
<span class="label">6.</span><cite>Finn RS, Martin M, Rugo HS, Jones S, Im SA, Gelmon K, et al. Palbociclib and letrozole in advanced breast Cancer. N Engl J Med. 2016;375(20):1925–36.
</cite> [<a href="https://doi.org/10.1056/NEJMoa1607303" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27959613/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Finn%20RS,%20Martin%20M,%20Rugo%20HS,%20Jones%20S,%20Im%20SA,%20Gelmon%20K,%20et%20al.%20Palbociclib%20and%20letrozole%20in%20advanced%20breast%20Cancer.%20N%20Engl%20J%20Med.%202016;375(20):1925%E2%80%9336." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR7">
<span class="label">7.</span><cite>Slamon DJ, Neven P, Chia S, Jerusalem G, De Laurentiis M, Im S, et al. Ribociclib plus fulvestrant for postmenopausal women with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer in the phase III randomized MONALEESA-3 trial: updated overall survival. Ann Oncol Off J Eur Soc Med Oncol. 2021;32(8):1015–24.</cite> [<a href="https://doi.org/10.1016/j.annonc.2021.05.353" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34102253/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Slamon%20DJ,%20Neven%20P,%20Chia%20S,%20Jerusalem%20G,%20De%20Laurentiis%20M,%20Im%20S,%20et%20al.%20Ribociclib%20plus%20fulvestrant%20for%20postmenopausal%20women%20with%20hormone%20receptor-positive,%20human%20epidermal%20growth%20factor%20receptor%202-negative%20advanced%20breast%20cancer%20in%20the%20phase%20III%20randomized%20MONALEESA-3%20trial:%20updated%20overall%20survival.%20Ann%20Oncol%20Off%20J%20Eur%20Soc%20Med%20Oncol.%202021;32(8):1015%E2%80%9324." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR8">
<span class="label">8.</span><cite>Hortobagyi GN, Stemmer SM, Burris HA, Yap YS, Sonke GS, Paluch-Shimon S, et al. Ribociclib as First-Line therapy for HR-Positive, advanced breast Cancer. N Engl J Med. 2016;375(18):1738–48.
</cite> [<a href="https://doi.org/10.1056/NEJMoa1609709" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27717303/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Hortobagyi%20GN,%20Stemmer%20SM,%20Burris%20HA,%20Yap%20YS,%20Sonke%20GS,%20Paluch-Shimon%20S,%20et%20al.%20Ribociclib%20as%20First-Line%20therapy%20for%20HR-Positive,%20advanced%20breast%20Cancer.%20N%20Engl%20J%20Med.%202016;375(18):1738%E2%80%9348." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR9">
<span class="label">9.</span><cite>Johnston SRD, Harbeck N, Hegg R, Toi M, Martin M, Shao ZM, et al. Abemaciclib combined with endocrine therapy for the adjuvant treatment of HR+, HER2-, Node-Positive, High-Risk, early breast Cancer (monarchE). J Clin Oncol Off J Am Soc Clin Oncol. 2020;38(34):3987–98.</cite> [<a href="https://doi.org/10.1200/JCO.20.02514" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7768339/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32954927/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Johnston%20SRD,%20Harbeck%20N,%20Hegg%20R,%20Toi%20M,%20Martin%20M,%20Shao%20ZM,%20et%20al.%20Abemaciclib%20combined%20with%20endocrine%20therapy%20for%20the%20adjuvant%20treatment%20of%20HR+,%20HER2-,%20Node-Positive,%20High-Risk,%20early%20breast%20Cancer%20(monarchE).%20J%20Clin%20Oncol%20Off%20J%20Am%20Soc%20Clin%20Oncol.%202020;38(34):3987%E2%80%9398." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR10">
<span class="label">10.</span><cite>Cejuela M, Gil-Torralvo A, Castilla MÁ, Domínguez-Cejudo MÁ, Falcón A, Benavent M, et al. Abemaciclib, Palbociclib, and ribociclib in Real-World data: A direct comparison of First-Line treatment for Endocrine-Receptor-Positive metastatic breast Cancer. Int J Mol Sci. 2023;24(10):8488.
</cite> [<a href="https://doi.org/10.3390/ijms24108488" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10217927/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37239834/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Cejuela%20M,%20Gil-Torralvo%20A,%20Castilla%20M%C3%81,%20Dom%C3%ADnguez-Cejudo%20M%C3%81,%20Falc%C3%B3n%20A,%20Benavent%20M,%20et%20al.%20Abemaciclib,%20Palbociclib,%20and%20ribociclib%20in%20Real-World%20data:%20A%20direct%20comparison%20of%20First-Line%20treatment%20for%20Endocrine-Receptor-Positive%20metastatic%20breast%20Cancer.%20Int%20J%20Mol%20Sci.%202023;24(10):8488." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR11">
<span class="label">11.</span><cite>Christiansen EA, Kümler I. Real-world effectiveness of Palbociclib in HR+/HER2- metastatic breast cancer: a literature review. Future Sci OA. 2024;10(1):2340329.</cite> [<a href="https://doi.org/10.2144/fsoa-2023-0074" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11137848/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38817360/" class="usa-link">PubMed</a>]</li>
<li id="CR12">
<span class="label">12.</span><cite>Petrelli F, Ghidini A, Pedersini R, Cabiddu M, Borgonovo K, Parati MC, et al. Comparative efficacy of Palbociclib, ribociclib and abemaciclib for ER + metastatic breast cancer: an adjusted indirect analysis of randomized controlled trials. Breast Cancer Res Treat. 2019;174(3):597–604.
</cite> [<a href="https://doi.org/10.1007/s10549-019-05133-y" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30659432/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Petrelli%20F,%20Ghidini%20A,%20Pedersini%20R,%20Cabiddu%20M,%20Borgonovo%20K,%20Parati%20MC,%20et%20al.%20Comparative%20efficacy%20of%20Palbociclib,%20ribociclib%20and%20abemaciclib%20for%20ER%E2%80%89+%E2%80%89metastatic%20breast%20cancer:%20an%20adjusted%20indirect%20analysis%20of%20randomized%20controlled%20trials.%20Breast%20Cancer%20Res%20Treat.%202019;174(3):597%E2%80%93604." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR13">
<span class="label">13.</span><cite>Tong F, Lu Y, Ma HF, Shen J. Comparative efficacy and safety of CDK4/6 inhibitors combined with endocrine therapies for HR+/HER2-breast cancer: systematic review and network meta-analysis. Heliyon. 2024;10(11):e31583.
</cite> [<a href="https://doi.org/10.1016/j.heliyon.2024.e31583" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11145204/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38832268/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Tong%20F,%20Lu%20Y,%20Ma%20HF,%20Shen%20J.%20Comparative%20efficacy%20and%20safety%20of%20CDK4/6%20inhibitors%20combined%20with%20endocrine%20therapies%20for%20HR+/HER2-breast%20cancer:%20systematic%20review%20and%20network%20meta-analysis.%20Heliyon.%202024;10(11):e31583." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR14">
<span class="label">14.</span><cite>Rath S, Elamarthi P, Parab P, Gulia S, Nandhana R, Mokal S, et al. Efficacy and safety of Palbociclib and ribociclib in patients with Estrogen and/or progesterone receptor positive, HER2 receptor negative metastatic breast cancer in routine clinical practice. PLoS ONE. 2021;16(7):e0253722.
</cite> [<a href="https://doi.org/10.1371/journal.pone.0253722" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8297817/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34292933/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Rath%20S,%20Elamarthi%20P,%20Parab%20P,%20Gulia%20S,%20Nandhana%20R,%20Mokal%20S,%20et%20al.%20Efficacy%20and%20safety%20of%20Palbociclib%20and%20ribociclib%20in%20patients%20with%20Estrogen%20and/or%20progesterone%20receptor%20positive,%20HER2%20receptor%20negative%20metastatic%20breast%20cancer%20in%20routine%20clinical%20practice.%20PLoS%20ONE.%202021;16(7):e0253722." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR15">
<span class="label">15.</span><cite>Ganguly S, Mukherjee N, Mandal S, Roy S, Agarwal S, Biswas B et al. Efficacy of cyclin-dependent kinase 4/6 inhibitors in patients with metastatic hormone positive breast cancer: a single institutional study from India [Internet]. 2022 [cited 2024 Oct 2]. Available from: <a href="http://ecancer.org/en/journal/article/1450-efficacy-of-cyclin-dependent-kinase-4-6-inhibitors-in-patients-with-metastatic-hormone-positive-breast-cancer-a-single-institutional-study-from-india" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://ecancer.org/en/journal/article/1450-efficacy-of-cyclin-dependent-kinase-4-6-inhibitors-in-patients-with-metastatic-hormone-positive-breast-cancer-a-single-institutional-study-from-india</a></cite> [<a href="https://doi.org/10.3332/ecancer.2022.1450" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9666281/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36405937/" class="usa-link">PubMed</a>]</li>
<li id="CR16">
<span class="label">16.</span><cite>Gogia A, Arora S, Choudhary P, Kumar R, Thulkar S, Sharma D, et al. Real-world Indian scenario of CDK4/6 inhibitors (palbociclib and ribociclib) with endocrine therapy in upfront hormone positive metastatic breast cancer. J Clin Oncol. 2021;39:e13028–13028.</cite> [<a href="https://scholar.google.com/scholar_lookup?Gogia%20A,%20Arora%20S,%20Choudhary%20P,%20Kumar%20R,%20Thulkar%20S,%20Sharma%20D,%20et%20al.%20Real-world%20Indian%20scenario%20of%20CDK4/6%20inhibitors%20(palbociclib%20and%20ribociclib)%20with%20endocrine%20therapy%20in%20upfront%20hormone%20positive%20metastatic%20breast%20cancer.%20J%20Clin%20Oncol.%202021;39:e13028%E2%80%9313028." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR17">
<span class="label">17.</span><cite>Das Majumdar SK, Barik SK, Pattanaik A, Das DK, Parida DK. Role of Cyclin-Dependent Kinase 4/6 in Metastatic Breast Cancer: Real-World Data From a Tertiary Care Institute in Eastern India. Cureus [Internet]. 2024 Jan 12 [cited 2024 Oct 2]; Available from: <a href="https://www.cureus.com/articles/151412-role-of-cyclin-dependent-kinase-46-in-metastatic-breast-cancer-real-world-data-from-a-tertiary-care-institute-in-eastern-india" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.cureus.com/articles/151412-role-of-cyclin-dependent-kinase-46-in-metastatic-breast-cancer-real-world-data-from-a-tertiary-care-institute-in-eastern-india</a></cite> [<a href="https://doi.org/10.7759/cureus.52172" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10859150/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38344632/" class="usa-link">PubMed</a>]</li>
<li id="CR18">
<span class="label">18.</span><cite>Rugo HS, Rumble RB, Macrae E, Barton DL, Connolly HK, Dickler MN, et al. Endocrine therapy for hormone Receptor-Positive metastatic breast cancer: American society of clinical oncology guideline. J Clin Oncol Off J Am Soc Clin Oncol. 2016;34(25):3069–103.</cite> [<a href="https://doi.org/10.1200/JCO.2016.67.1487" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27217461/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Rugo%20HS,%20Rumble%20RB,%20Macrae%20E,%20Barton%20DL,%20Connolly%20HK,%20Dickler%20MN,%20et%20al.%20Endocrine%20therapy%20for%20hormone%20Receptor-Positive%20metastatic%20breast%20cancer:%20American%20society%20of%20clinical%20oncology%20guideline.%20J%20Clin%20Oncol%20Off%20J%20Am%20Soc%20Clin%20Oncol.%202016;34(25):3069%E2%80%93103." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR19">
<span class="label">19.</span><cite>George M, Qureshi S, Omene C, Toppmeyer D, Ganesan S. Clinical and Pharmacologic differences of CDK4/6 inhibitors in breast Cancer. Front Oncol. 2021;11:693104.
</cite> [<a href="https://doi.org/10.3389/fonc.2021.693104" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8313476/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34327137/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?George%20M,%20Qureshi%20S,%20Omene%20C,%20Toppmeyer%20D,%20Ganesan%20S.%20Clinical%20and%20Pharmacologic%20differences%20of%20CDK4/6%20inhibitors%20in%20breast%20Cancer.%20Front%20Oncol.%202021;11:693104." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR20">
<span class="label">20.</span><cite>Dajsakdipon T, Susiriwatananont T, Wongkraisri C, Ithimakin S, Parinyanitikul N, Supavavej A, et al. Comparative effectiveness analysis of survival with first-line Palbociclib or ribociclib plus AI in HR + /HER2- advanced breast cancer (CEPRA study): preliminary analysis of real-world data from Thailand. BMC Cancer. 2024;24:1018.
</cite> [<a href="https://doi.org/10.1186/s12885-024-12765-x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11328387/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39152401/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Dajsakdipon%20T,%20Susiriwatananont%20T,%20Wongkraisri%20C,%20Ithimakin%20S,%20Parinyanitikul%20N,%20Supavavej%20A,%20et%20al.%20Comparative%20effectiveness%20analysis%20of%20survival%20with%20first-line%20Palbociclib%20or%20ribociclib%20plus%20AI%20in%20HR%20+%20/HER2-%20advanced%20breast%20cancer%20(CEPRA%20study):%20preliminary%20analysis%20of%20real-world%20data%20from%20Thailand.%20BMC%20Cancer.%202024;24:1018." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR21">
<span class="label">21.</span><cite>Onesti CE, Jerusalem G. CDK4/6 inhibitors in breast cancer: differences in toxicity profiles and impact on agent choice. A systematic review and meta-analysis. Expert Rev Anticancer Ther. 2021;21(3):283–98.
</cite> [<a href="https://doi.org/10.1080/14737140.2021.1852934" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33233970/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Onesti%20CE,%20Jerusalem%20G.%20CDK4/6%20inhibitors%20in%20breast%20cancer:%20differences%20in%20toxicity%20profiles%20and%20impact%20on%20agent%20choice.%20A%20systematic%20review%20and%20meta-analysis.%20Expert%20Rev%20Anticancer%20Ther.%202021;21(3):283%E2%80%9398." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR22">
<span class="label">22.</span><cite>Ibrance. (palbociclib) dosing, indications, interactions, adverse effects, and more [Internet]. [cited 2024 Oct 2]. Available from: <a href="https://reference.medscape.com/drug/ibrance-palbociclib-999995" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://reference.medscape.com/drug/ibrance-palbociclib-999995</a></cite>
</li>
<li id="CR23">
<span class="label">23.</span><cite>Kisqali. (ribociclib) dosing, indications, interactions, adverse effects, and more [Internet]. [cited 2024 Oct 2]. Available from: <a href="https://reference.medscape.com/drug/kisqali-ribociclib-1000154" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://reference.medscape.com/drug/kisqali-ribociclib-1000154</a></cite>
</li>
<li id="CR24">
<span class="label">24.</span><cite>Zhu L, Wang M, Luo X, Li H, Shan H, Du Q, et al. Pharmacoeconomic evaluations of CDK4/6 inhibitors plus endocrine therapy for advanced hormone receptor-positive (HR+) and human epidermal growth factor receptor-2 negative (HER2–) breast cancer: a systematic review. Ann Transl Med. 2022;10(4):233–233.
</cite> [<a href="https://doi.org/10.21037/atm-21-5110" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8908180/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35280368/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zhu%20L,%20Wang%20M,%20Luo%20X,%20Li%20H,%20Shan%20H,%20Du%20Q,%20et%20al.%20Pharmacoeconomic%20evaluations%20of%20CDK4/6%20inhibitors%20plus%20endocrine%20therapy%20for%20advanced%20hormone%20receptor-positive%20(HR+)%20and%20human%20epidermal%20growth%20factor%20receptor-2%20negative%20(HER2%E2%80%93)%20breast%20cancer:%20a%20systematic%20review.%20Ann%20Transl%20Med.%202022;10(4):233%E2%80%93233." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR25">
<span class="label">25.</span><cite>Cameron D, Kumar Sharma V, Biswas C, Clarke C, Chandiwana D, Pathak P. Cost-effectiveness of ribociclib versus Palbociclib in combination with an aromatase inhibitor as first-line treatment of postmenopausal women with HR+/HER2– advanced breast cancer: analysis based on final OS results of MONALEESA-2 and PALOMA-2. J Med Econ. 2023;26(1):357–65.
</cite> [<a href="https://doi.org/10.1080/13696998.2023.2182051" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36797664/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Cameron%20D,%20Kumar%20Sharma%20V,%20Biswas%20C,%20Clarke%20C,%20Chandiwana%20D,%20Pathak%20P.%20Cost-effectiveness%20of%20ribociclib%20versus%20Palbociclib%20in%20combination%20with%20an%20aromatase%20inhibitor%20as%20first-line%20treatment%20of%20postmenopausal%20women%20with%20HR+/HER2%E2%80%93%E2%80%89advanced%20breast%20cancer:%20analysis%20based%20on%20final%20OS%20results%20of%20MONALEESA-2%20and%20PALOMA-2.%20J%20Med%20Econ.%202023;26(1):357%E2%80%9365." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR26">
<span class="label">26.</span><cite>Sra MS, Sasi A, Batra A, Bakhshi S, Ganguly S. Cost-Effectiveness of adjuvant abemaciclib and ribociclib in High-Risk hormone Receptor–Positive early breast cancer: an Indian perspective. JCO Glob Oncol. 2024;(10):e2300433.</cite> [<a href="https://doi.org/10.1200/GO.23.00433" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39024528/" class="usa-link">PubMed</a>]</li>
<li id="CR27">
<span class="label">27.</span><cite>Gupta N, Gupta D, Dixit J, Mehra N, Singh A, nookala krishnamurthy M et al. Cost effectiveness of ribociclib and Palbociclib in the Second-Line treatment of hormone Receptor-Positive, HER2-Negative metastatic breast Cancer in Post-Menopausal Indian women. Appl Health Econ Health Policy. 2022;20.</cite> [<a href="https://doi.org/10.1007/s40258-022-00731-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35534752/" class="usa-link">PubMed</a>]</li>
<li id="CR28">
<span class="label">28.</span><cite>Lee JS, Yost SE, Li SM, Cui Y, Frankel PH, Yuan YC, et al. Genomic markers of CDK 4/6 inhibitor resistance in hormone receptor positive metastatic breast Cancer. Cancers. 2022;14(13):3159.
</cite> [<a href="https://doi.org/10.3390/cancers14133159" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9264913/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35804935/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Lee%20JS,%20Yost%20SE,%20Li%20SM,%20Cui%20Y,%20Frankel%20PH,%20Yuan%20YC,%20et%20al.%20Genomic%20markers%20of%20CDK%204/6%20inhibitor%20resistance%20in%20hormone%20receptor%20positive%20metastatic%20breast%20Cancer.%20Cancers.%202022;14(13):3159." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR29">
<span class="label">29.</span><cite>Foy R, Lew KX, Saurin AT. The search for CDK4/6 inhibitor biomarkers has been hampered by inappropriate proliferation assays. Npj Breast Cancer. 2024;10(1):1–11.
</cite> [<a href="https://doi.org/10.1038/s41523-024-00624-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10912267/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38438376/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Foy%20R,%20Lew%20KX,%20Saurin%20AT.%20The%20search%20for%20CDK4/6%20inhibitor%20biomarkers%20has%20been%20hampered%20by%20inappropriate%20proliferation%20assays.%20Npj%20Breast%20Cancer.%202024;10(1):1%E2%80%9311." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR30">
<span class="label">30.</span><cite>Stanciu IM, Parosanu AI, Orlov-Slavu C, Iaciu IC, Popa AM, Olaru CM, et al. Mechanisms of resistance to CDK4/6 inhibitors and predictive biomarkers of response in HR+/HER2-Metastatic breast Cancer—A review of the literature. Diagnostics. 2023;13(5):987.
</cite> [<a href="https://doi.org/10.3390/diagnostics13050987" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10000620/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36900131/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Stanciu%20IM,%20Parosanu%20AI,%20Orlov-Slavu%20C,%20Iaciu%20IC,%20Popa%20AM,%20Olaru%20CM,%20et%20al.%20Mechanisms%20of%20resistance%20to%20CDK4/6%20inhibitors%20and%20predictive%20biomarkers%20of%20response%20in%20HR+/HER2-Metastatic%20breast%20Cancer%E2%80%94A%20review%20of%20the%20literature.%20Diagnostics.%202023;13(5):987." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ul></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title">Associated Data</h2>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
<section id="_adsm93_" lang="en" class="supplementary-materials"><h3 class="pmc_sec_title">Supplementary Materials</h3>
<section class="sm xbox font-sm" id="db_ds_supplementary-material1_reqid_"><div class="media p"><div class="caption">
<a href="/articles/instance/12362974/bin/12885_2025_14270_MOESM1_ESM.docx" data-ga-action="click_feat_suppl" class="usa-link">Supplementary Material 1</a><sup> (75.2KB, docx) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material2_reqid_"><div class="media p"><div class="caption">
<a href="/articles/instance/12362974/bin/12885_2025_14270_MOESM2_ESM.xlsx" data-ga-action="click_feat_suppl" class="usa-link">Supplementary Material 2</a><sup> (16.7KB, xlsx) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material3_reqid_"><div class="media p"><div class="caption">
<a href="/articles/instance/12362974/bin/12885_2025_14270_MOESM3_ESM.docx" data-ga-action="click_feat_suppl" class="usa-link">Supplementary Material 3</a><sup> (46.8KB, docx) </sup>
</div></div></section></section><section id="_adda93_" lang="en" class="data-availability-statement"><h3 class="pmc_sec_title">Data Availability Statement</h3>
<p>The datasets generated and analyzed during the current study are provided as supplementary material in the form of an MS Excel file for ease of access and reproducibility.</p></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from BMC Cancer are provided here courtesy of <strong>BMC</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.1186/s12885-025-14270-1"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/12885_2025_Article_14270.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (1.4 MB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/12362974/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/12362974/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12362974%2F%3Freport%3Dclassic%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12362974/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC12362974/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC12362974/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/40826034/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC12362974/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/40826034/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC12362974/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/12362974/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="3tbZwgYRLcBBBxXNg3qMowwK8jIuc5IZoLpHaOxemvqHJXdt66a2o6bDZnri6m9K">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Web Policies
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            FOIA
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS Vulnerability Disclosure
        

        
    </a>


                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Help
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Accessibility
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Careers
        

        
    </a>


                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NLM
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NIH
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            USA.gov
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-133c6271.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-44d04358.js"></script>
    
    

    </body>
</html>
